Ticker
ADVMCompany Name
ADVERUM BIOTECHNOLOGIES INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Goodwill and Intangibles | Goodwill & Intangibles to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 96.18M | $ 0 | 0% |
3/31/2025 | $ 137.65M | $ 0 | 0% |
12/31/2024 | $ 179.84M | $ 0 | 0% |
9/30/2024 | $ 234.38M | $ 0 | 0% |
6/30/2024 | $ 253.8M | $ 0 | 0% |
3/31/2024 | $ 267.83M | $ 0 | 0% |
12/31/2023 | $ 173.01M | $ 0 | 0% |
9/30/2023 | $ 196.77M | $ 0 | 0% |
6/30/2023 | $ 241.43M | $ 0 | 0% |
3/31/2023 | $ 275.58M | $ 0 | 0% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Intangibles / Assets
(=) Intang. to Assets
Intang. to Assets for ADVERUM BIOTECHNOLOGIES INC is calculated as follows: Intangibles [ $ 0 ] / Assets [ $ 507.71M ]
(=) Intang. to Assets [ 0% ]
Minimum
Sep 30, 2020
Maximum
Sep 30, 2020
Average
Median
filtered constituents | 3.23K |
---|---|
min | 0% |
max | 23.21% |
average | 3.99% |
median | 0.52% |
std | 6.09% |